Hanmi Pharm. Co., Ltd. (KRX:128940)
239,500
+4,000 (1.70%)
At close: Apr 18, 2025, 3:30 PM KST
Hanmi Pharm. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 121,315 | 146,231 | 82,792 | 67,025 | 11,959 | Upgrade
|
Depreciation & Amortization | 97,331 | 98,454 | 96,842 | 89,086 | 61,339 | Upgrade
|
Loss (Gain) From Sale of Assets | -27.74 | -1,769 | -451.65 | 1,062 | 313.72 | Upgrade
|
Asset Writedown & Restructuring Costs | 2,488 | 9,153 | 3,794 | 535.2 | -470.68 | Upgrade
|
Loss (Gain) From Sale of Investments | 87.92 | -2,630 | -47.09 | - | 4,514 | Upgrade
|
Loss (Gain) on Equity Investments | 9.2 | -1,258 | 8,537 | 4.02 | 0.02 | Upgrade
|
Provision & Write-off of Bad Debts | -593.89 | 1,277 | 723.06 | 5,118 | 374.19 | Upgrade
|
Other Operating Activities | 63,140 | 24,476 | 43,766 | 92,609 | 31,431 | Upgrade
|
Change in Accounts Receivable | -61,052 | -3,217 | 37,286 | -76,613 | 32,478 | Upgrade
|
Change in Inventory | 1,928 | -16,903 | -14,365 | 18,916 | 4,885 | Upgrade
|
Change in Accounts Payable | -10,438 | 5,574 | -2,736 | 9,794 | -5,308 | Upgrade
|
Change in Other Net Operating Assets | -20,701 | -42,852 | -93,870 | -5,613 | 10,020 | Upgrade
|
Operating Cash Flow | 193,487 | 216,538 | 162,269 | 201,923 | 151,535 | Upgrade
|
Operating Cash Flow Growth | -10.64% | 33.44% | -19.64% | 33.25% | 1117.48% | Upgrade
|
Capital Expenditures | -39,261 | -27,352 | -30,378 | -19,949 | -41,815 | Upgrade
|
Sale of Property, Plant & Equipment | 50.86 | 2,600 | 1,397 | 86.37 | 80.8 | Upgrade
|
Sale (Purchase) of Intangibles | -22,768 | -16,156 | -20,273 | -14,199 | -15,935 | Upgrade
|
Investment in Securities | 103,827 | -138,865 | -118,609 | -6,953 | 13,994 | Upgrade
|
Other Investing Activities | -3,650 | -3,699 | -13,545 | -2,375 | -1,491 | Upgrade
|
Investing Cash Flow | 24,851 | -183,472 | -181,408 | -43,389 | -45,166 | Upgrade
|
Short-Term Debt Issued | 431,830 | 134,650 | 230,000 | 102,700 | 159,200 | Upgrade
|
Long-Term Debt Issued | 49,000 | - | 7,000 | 30,000 | 21,800 | Upgrade
|
Total Debt Issued | 480,830 | 134,650 | 237,000 | 132,700 | 181,000 | Upgrade
|
Short-Term Debt Repaid | -472,330 | -202,650 | -116,800 | -198,800 | -184,200 | Upgrade
|
Long-Term Debt Repaid | -86,431 | -37,720 | -147,240 | -36,476 | -50,766 | Upgrade
|
Total Debt Repaid | -558,761 | -240,370 | -264,040 | -235,276 | -234,966 | Upgrade
|
Net Debt Issued (Repaid) | -77,931 | -105,720 | -27,040 | -102,576 | -53,966 | Upgrade
|
Repurchase of Common Stock | -3,280 | -3,071 | -3,834 | -4,874 | -3,083 | Upgrade
|
Dividends Paid | -12,555 | -17,996 | -5,992 | -5,881 | -8,140 | Upgrade
|
Other Financing Activities | - | -0 | - | - | - | Upgrade
|
Financing Cash Flow | -93,767 | -126,787 | -36,867 | -113,331 | -65,190 | Upgrade
|
Foreign Exchange Rate Adjustments | 12,727 | 1,373 | -5,890 | 17,864 | -1,134 | Upgrade
|
Net Cash Flow | 137,297 | -92,348 | -61,896 | 63,067 | 40,044 | Upgrade
|
Free Cash Flow | 154,226 | 189,186 | 131,890 | 181,974 | 109,719 | Upgrade
|
Free Cash Flow Growth | -18.48% | 43.44% | -27.52% | 65.85% | - | Upgrade
|
Free Cash Flow Margin | 10.31% | 12.69% | 9.90% | 15.12% | 10.20% | Upgrade
|
Free Cash Flow Per Share | 12162.13 | 14906.67 | 10382.37 | 14307.73 | 8617.07 | Upgrade
|
Cash Interest Paid | 24,747 | 27,846 | 19,498 | 18,315 | 23,596 | Upgrade
|
Cash Income Tax Paid | 22,120 | 31,432 | 29,632 | 6,599 | 14,693 | Upgrade
|
Levered Free Cash Flow | 132,235 | 156,408 | 193,044 | 159,618 | 64,927 | Upgrade
|
Unlevered Free Cash Flow | 147,468 | 174,226 | 207,199 | 169,979 | 80,469 | Upgrade
|
Change in Net Working Capital | 20,653 | 21,273 | -64,823 | -36,655 | -46,269 | Upgrade
|
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.